Abstract: A compound including a bidentate ligand LA comprising a structure of Formula I, is disclosed. In Formula I, ring A? is a 7-, 8-, or 9-membered ring structure; X is of NR2, O, CR, CRR?, S, or SiRR?; each of RA?, R1, and R2 is independently hydrogen or a substituent; R1? is independently absent or a hydrogen or a substituent; any two adjacent RA?, R1, R1?, and R2 can be joined or fused to form a ring; the ligand LA is coordinated to a metal, which is selected from Os, Ir, Pd, Pt, Cu, Ag, or Au; and (1) at least one of R1 and R2 is coordinated to the metal M, or (2) at least one RA? comprises a 5- or 6-membered carbocyclic or heterocyclic ring that is not directly fused to Ring A? and is coordinated to the metal M, or both (1) and (2) are true. Formulations, devices, and consumer products including the compound are also disclosed.

Abstract: Provided are organometallic compounds including a ligand LA of the following Formula I Also provided are formulations including these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: A compound comprising a first ligand LA, where LA comprises a structure of Formula I, is provided. In Formula I, each of X1, X2, X3, and X4 represents CR, CRR?, NR, or N; Y is selected from a linking group; each of R, R?, R?, R1, R1?, R2, R2?, R3, R3?, R4, and R4? is hydrogen or a substituent; each represents a single bond or a double bond; any two adjacent substituents may be joined or fused to form a ring; two adjacent ones of R1, R2, R3, and R4 are joined together to form a fused 5-membered heterocyclic ring, Ring A, while the remaining two of R1, R2, R3, and R4 cannot be joined to form an aromatic ring; and Ring A is joined to a metal M by a direct bond. Formulations, OLEDs, and consumer products comprising the compound are also provided.

Abstract: A compound including a first bidentate ligand LA that includes a structure of Formula I, are provided. The ligand LA is coordinated to a metal M and can be joined with other ligands. In Formula I, in addition to some exclusions, each of X1, X2, X3, and X4 is C or N; two R1, R2, and R3 can be joined or fused to form a ring; and each R1, R2, and R3 is independently a group containing the metal M, a hydrogen, or a General Substituent defined herein. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Provided are compounds comprising ligands LA that are ligands of Pt and Ir complexes for OLED applications. Also provided are formulations comprising these compounds comprising ligands LA that are ligands of Pt and Ir complexes for OLED applications. Further provided are OLEDs and related consumer products that utilize these compounds comprising ligands LA that are ligands of Pt and Ir complexes for OLED applications.

Abstract: Provided are compounds comprising anionic bidentate ligands LA that are ligands of Pt and Ir complexes for OLED applications. Also provided are formulations comprising these compounds comprising anionic bidentate ligands LA that are ligands of Pt and Ir complexes for OLED applications. Further provided are OLEDs and related consumer products that utilize these compounds comprising anionic bidentate ligands LA that are ligands of Pt and Ir complexes for OLED applications.

Abstract: Provided are compounds having the structure of Formula I: wherein rings A, B, and D are each independently a 5-membered or 6-membered carbocyclic or heterocyclic ring; X1-X9 are each independently C or N; Y1 is selected from the group consisting of a direct bond, O, S, Se, NR, SiRR?, CRR?, and P(O)R; R, R?, RA, RB, RC, and RD each independently represents mono to the maximum allowable substitution, or no substitution; each R, R?, RA, RB, RC, and RD is independently a hydrogen or a substituent; and any two adjacent groups of RA, RB, RC, and RD may be joined or fused to form a ring Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: Provided are organometallic compounds including a ligand LA of a structure of Formula I Also provided are formulations including these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: Provided are high triplet host compounds based on a multiphenylene macrocycle which comprises at least one group L1 selected from the group consisting of O, S, Se, BR, BRR?, CRR?, SiRR?, and GeRR? which links two phenylene groups. Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: A compound comprising a ligand LA of Formula I, is disclosed. In Formula I, each of Z1, Z2, Z3, Z4, Z5, and Z6 is C or N; K is selected from a direct bond, O, and S; if K is O or S, then Z6 is C; ligand LA is coordinated to a metal by the dash lines; M is coordinated to at least one other ligand; L1 is an organic linker; if M is selected from Ru, Os, or Ir, then K is O or S; if M is selected from Pt, Pd, Cu, Ag, or Au, and K is a direct bond, then M forms at least one bond to oxygen or sulfur; when M is selected from Pt, Pd, Cu, Ag, or Au, and K is O or S, then L1 is selected from —CR?N—, —CR?R?CR?R?—, —NR?BR?—, —CR?R?O—, —CR?R?S—, —CR??CR?O—, —CR??CR?S—, —CR??CR?NR—, —CR??CR?CR2—, —C(?N—)—, and —C(?CR—)—.

Abstract: Systems, devices, and methods for linking orders to develop a consolidated audit trail (CAT) are configured to receive event data for one or more orders based on one or more order characteristics; determine linkages between the one or more orders based on parent relationships of the one or more orders; verify the linkages between the one or more orders based on the event data; and determine order lifecycles based on the linkages between the one or more orders.

Abstract: Systems, devices, and methods for linking orders to develop a consolidated audit trail (CAT) are configured to receive event data for one or more orders based on one or more order characteristics; determine linkages between the one or more orders based on parent relationships of the one or more orders; verify the linkages between the one or more orders based on the event data; and determine order lifecycles based on the linkages between the one or more orders.

Abstract: Provided are compounds comprising a ligand LA of Formula I

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: Systems, devices, and methods for linking orders to develop a consolidated audit trail (CAT) are configured to receive event data for one or more orders based on one or more order characteristics; determine linkages between the one or more orders based on parent relationships of the one or more orders; verify the linkages between the one or more orders based on the event data; and determine order lifecycles based on the linkages between the one or more orders.

Abstract: Systems, devices, and methods for linking orders to develop a consolidated audit trail (CAT) are configured to receive event data for one or more orders based on one or more order characteristics; determine linkages between the one or more orders based on parent relationships of the one or more orders; verify the linkages between the one or more orders based on the event data; and determine order lifecycles based on the linkages between the one or more orders.

Abstract: Systems, devices, and methods for linking orders to develop a consolidated audit trail (CAT) are configured to receive event data for one or more orders based on one or more order characteristics; determine linkages between the one or more orders based on parent relationships of the one or more orders; verify the linkages between the one or more orders based on the event data; and determine order lifecycles based on the linkages between the one or more orders.

Abstract: Systems, devices, and methods for linking orders to develop a consolidated audit trail (CAT) are configured to receive event data for one or more orders based on one or more order characteristics; determine linkages between the one or more orders based on parent relationships of the one or more orders; verify the linkages between the one or more orders based on the event data; and determine order lifecycles based on the linkages between the one or more orders.

Abstract: Systems, devices, and methods for linking orders to develop a consolidated audit trail (CAT) are configured to receive event data for one or more orders based on one or more order characteristics; determine linkages between the one or more orders based on parent relationships of the one or more orders; verify the linkages between the one or more orders based on the event data; and determine order lifecycles based on the linkages between the one or more orders.

Abstract: A method of magnetic resonance imaging includes subjecting a region of a patient being imaged to magnetic resonance imaging pulse sequences thereby generating magnetic resonance echoes emanating from the region. The echoes are encoded with magnetic gradients and collected as k-space data in separate consecutive acquisitions. Each acquisition successively fills in one of a number of distinct subsets of k-space based on the encoding of the collected echoes for that acquisition. In turn, a reconstruction algorithm is applied to the k-space data after each acquisition to generate a series of temporally updated image representations of the region. Further, a magnetic resonance imaging apparatus for performing the method is also provided.